Ghrelin: From discovery to cancer cachexia therapy

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 17, Issue 5, 2014, Pages 471-476

  Molfino, Alessio ^a   Formiconi, Alessandra ^a   Fanelli, Filippo Rossi ^a   Muscaritoli, Maurizio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

cachexia; cancer; ghrelin; growth hormone secretagogue receptor agonist; growth hormone secretagogue receptor antagonist; muscle wasting

Indexed keywords

ANAMORELIN; ATROGIN 1; BIM 28125; BIM 28131; CISPLATIN; GHRELIN; GHRELIN RECEPTOR; GLUCOSE; JMV 2810; L 163255; MUSCLE RING FINGER 1 PROTEIN; MYOSTATIN; ONO 7643; UNCLASSIFIED DRUG;

ANOREXIA; ANTIINFLAMMATORY ACTIVITY; BODY MASS; CACHEXIA; CANCER CHEMOTHERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG SELECTIVITY; ESOPHAGUS RESECTION; GASTRECTOMY; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; MUSCLE ATROPHY; NAUSEA; NONHUMAN; PLEIOTROPY; REVIEW; SIDE EFFECT; TUMOR GROWTH; COMPLICATION; MUSCULAR ATROPHY; NEOPLASM; WASTING SYNDROME;

CACHEXIA; GHRELIN; HUMANS; MUSCULAR ATROPHY; NEOPLASMS; WASTING SYNDROME;

EID: 84906090219     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000075     Document Type: Review

References (45)

1. Molfino A, Gioia G, Muscaritoli M. The hunger hormone gherlin in cachexia. Expert Opin Biol Ther 2013; 13:465-468
2. Gahete MD, Rincón-Fernández D, Villa-Osaba A, et al. Ghrelin gene products, receptors, and GOAT enzyme: Biological and pathophysiological insight. J Endocrinol 2013; 2220-2224
3. Wellman PJ, Clifford PS, Rodriguez JA. Ghrelin and ghrelin receptor modulation of psychostimulant action. Front Neurosci 2013; 25:171
4. Zhang W, Zhang C, Fritze D, et al. Modulation of food intake by mTOR signaling in the dorsal motor nucleus of vagus in male rats: Focus on ghrelin and nesfatin-1. Exp Physiol 2013; 98:1696-1704
5. Gjesing AP, Larsen LH, Torekov SS, et al. Family and population based studies of variation within the ghrelin receptor locus in relation to measures of obesity. PLoS One 2010; 5:e10084
6. Müller TD, Tschöp MH, Jarick I, et al. Genetic variation of the ghrelin activator gene ghrelin O-Acyltransferase (GOAT) is associated with anorexia nervosa. J Psychiatr Res 2011; 45:706-711
7. Karra E, ODaly OG, Choudhury AI, et al. A link between FTO, ghrelin, and impaired brain food-cue responsivity. J Clin Invest 2013; 123:3539-3551
8. Takeda H, Muto S, Hattori T, et al. Rikkunshito ameliorates the agingassociated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition. Endocrinology 2010; 151:244-252
9. Ma X, Lin L, Qin G, et al. Ablations of ghrelin and ghrelin receptor exhibit differential metabolic phenotypes and thermogenic capacity during aging. PLoS One 2011; 6:e16391
10. Heppner KM, Tong J. Regulation of glucose metabolism by the ghrelin system: Multiple players and multiple actions. Eur J Endocrinol 2014; 14-0183
11. Lim CT, Kola B, Korbonits M. The ghrelin/GOAT/GHS-R system and energy metabolism. Rev Endocr Metab Disord 2011; 12:173-186
12. Porteiro B, Diaz-Ruiz A, Martinez G, et al. Ghrelin requires p53 to stimulate lipid storage in fat and liver. Endocrinology 2013; 154:3671-3679
13. Delhanty PJD, Van Der Lely AJ. Ghrelin and glucose homeostasis. Peptides 2011; 32:2309-2318
14. Lin L, Saha PK, Ma X, et al. Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell 2011; 10:996-1010
15. Konturek PC, Brzozowski T, Engel M, et al. Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves. J Physiol Pharmacol 2009; 60:41-47
16. Torsello A, Bresciani E, Ravelli M, et al. Novel domain selective ACE-inhibiting activity of synthetic growth hormone secretagogues. Pharmacol Res 2012; 66:317-324
17. Kishimoto I, Tokudome T, Hosoda H, et al. Ghrelin and cardiovascular diseases. J Cardiol 2012; 59:8-13
18. Sakurada T, Ro S, Onouchi T, et al. Comparison of the actions of acylated and desacylated ghrelin on acid secretion in the rat stomach. J Gastroenterol 2010; 45:1111-1120
19. Benso A, Calvi E, Gramaglia E, et al. Other than growth hormone neuroendocrine actions of ghrelin. Endocr Dev 2013; 25:59-68
20. Delhanty P, Van Der Eerden BC, Van Leeuwen JP. Ghrelin and bone. Biofactors 2014; 40:41-48
21. Choi HJ, Ki KH, Yang JY, et al. Chronic central administration of Ghrelin increases bone mass through a mechanism independent of appetite regulation. PLoS One 2013; 8:e65505
22. Nouh O, Abd Elfattah MM, Hassouna AA. Association between ghrelin levels and BMD: A cross sectional trial. Gynecol Endocrinol 2012; 28:570-572
23. Schellekens H, Finger BC, Dinan TG, Cryan JF. Ghrelin signalling and obesity: At the interface of stress, mood and food reward. Pharmacol Ther 2012; 13:316-326
24. Li E, Chung H, Kim Y, et al. Ghrelin directly stimulates adult hippocampal neurogenesis: Implications for learning and memory. Endocr J 2013; 60:781-789
25. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: An international consensus. Lancet Oncol 2011; 12:489-495
26. Northrup R, Kuroda K, Manning Duus E, et al. Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model. Support Care Cancer 2013; 21:2409-2415
27. Garcia JM, Friend J, Allen S. Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: A multicenter, randomized, double-blind, crossover, pilot study. Support Care Cancer 2013; 21:129-137
28. Garcia JM, Scherer T, Chen JA, et al. Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice. Endocrinology 2013; 154:3118-3129
29. Reano S, Graziani A, Filigheddu N. Acylated and unacylated ghrelin administration to blunt muscle wasting. Curr Opin Clin Nutr Metab Care 2014; 17:236-240
30. Sheriff S, Kadeer N, Joshi R, et al. Des-Acyl ghrelin exhibits pro-Anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats. Mol Cell Endocrinol 2012; 351:286-295
31. Lenk K, Palus S, Schur R, et al. Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model. J Cachexia Sarcopenia Muscle 2013; 4:63-69
32. Porporato PE, Filigheddu N, Reano S, et al. Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice. J Clin Invest 2013; 123:611-622
33. Liang QH, Liu Y, Wu SS, et al. Ghrelin inhibits the apoptosis of MC3T3-E1 cells through ERK and AKT signaling pathway. Toxicol Appl Pharmacol 2013; 272:591-597
34. Liantonio A, Gramegna G, Carbonara G, et al. Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structure. Endocrinology 2013; 154:3764-3775
35. Chopin LK, Seim I, Walpole CM, Herington AC. The ghrelin axis - does it have an appetite for cancer progression?. Endocr Rev 2012; 33:849-891
36. Bonfili L, Cuccioloni M, Cecarini V, et al. Ghrelin induces apoptosis in colon adenocarcinoma cells via proteasome inhibition and autophagy induction. Apoptosis 2013; 18:1188-1200
37. Argiles JM, Stemmler B. The potential of ghrelin in the treatment of cancer cachexia. Expert Opin Biol Ther 2013; 13:67-76
38. Akamizu T, Kangawa K. Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect. Peptides 2011; 32:2295-2300
39. Suzuki H, Asakawa A, Amitani H, et al. Ghrelin and cachexia in chronic kidney disease. Pediatr Nephrol 2013; 28:521-526
40. Adachi S, Takiguchi S, Okada K, et al. Effects of ghrelin administration after total gastrectomy: A prospective, randomized, placebo-controlled phase II study. Gastroenterology 2010; 138:1312-1320
41. Yamamoto K, Takiguchi S, Miyata H, et al. Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction. Surgery 2010; 148:31-38
42. Parker JA, Bloom SR. Hypothalamic neuropeptides and the regulation of appetite. Neuropharmacology 2012; 63:18-30
43. Ashitani J, Matsumoto N, Nakazato M. Ghrelin and its therapeutic potential for cachectic patients. Peptides 2009; 30:1951-1956
44. Verhulst PJ, Depoortere I. Ghrelins second life: From appetite stimulator to glucose regulator. World J Gastroenterol 2012; 18:3183-3195
45. DeBoer MD. The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: Efficacy and mechanism. Curr Pharm Des 2012; 18:4779-4799.